State Key Laboratory of Drug Research (SKLDR), which was approved by Chinese Academy of Sciences under the unremitting efforts of reorganizing the state key laboratory system, is recruiting a Deputy Director. The candidate is expected to help SKLDR to continuously improve the academic influence and the ability to transform new drug achievements into real productivity.
Trending - Altmetric
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights
Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice